[Federal Register Volume 61, Number 176 (Tuesday, September 10, 1996)]
[Notices]
[Page 47758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-23003]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the National Cancer 
Institute Board of Scientific Advisors Clinical Trials Working Group, 
September 16-17, 1996 at the Holiday Inn Chevy Chase, 5520 Wisconsin 
Avenue, Chevy Chase, Maryland.
    This meeting will be open to the public on September 16, 1996 from 
8:00 am to 8:30 am for introductory remarks and discussion of the 
Institutes Clinical Trails Extramural Program and September 17, 1996 
from 8:00 am to 2:00 pm to discuss priority setting in clinical trials.
    The meeting will be closed to the public on September 16, 1996 from 
8:30 am to recess and on September 17, 1996 from 2:00 pm to adjournment 
for discussion of confidential issues relating to the review, 
discussion and evaluation of individual programs and projects conducted 
by the Clinical Trials Extramural Program. These discussions will 
reveal confidential trade secrets or commercial property such as 
patentable material, and personal information including consideration 
of personnel qualifications and performance, the competence of 
individual investigators and similar matters, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    Information pertaining to the meeting may be obtained from Dr. John 
Cole, III, Executive Secretary, National Cancer Institute Clinical 
Trials Working Group, National Cancer Institute, 6130 Executive Blvd., 
EPN, Rm. 540, Bethesda, MD 20892, (301-496-1718). Individuals who plan 
to attend and need special assistance such as sign language 
interpretation or other reasonable accommodations should contact Dr. 
John Cole, III in advance of the meeting.

    Dated: August 30, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-23003 Filed 9-9-96; 8:45 am]
BILLING CODE 4140-01-M